Thus, the company would risk tort liability if (1) it failed to keep the agency fully informed about any facts relevant to the continuing rationale for its approval, or (2) the company's advertising or other communications misled physicians or consumers about the drug's safety or efficacy. (Indeed, one who knowingly did so would invite criminal prosecution.) A regulatory compliance defense (includ